Engagement of CD4 before TCR triggering regulates both Bax- and Fas (CD95)-mediated apoptosis

Journal of Immunology

Volumn 164, Issue 10, 2000, Pages 5078-5087

  Somma, Francesca ^a   Tuosto, Loretta ^a   Gilardini Montani, Maria Saveria ^b   Di Somma, M Maddalena ^a   Cundari, Enrico ^c   Piccolella, Enza ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF TUSCIA   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FAS ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4; PROTEIN BAX; PROTEIN BCL 2; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; CELL DEATH; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; MEMBRANE POTENTIAL; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION;

EID: 0034657780     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.10.5078     Document Type: Article

References (70)

1. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
2. Dhein, J., H. Walczak, C. Baumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by (APO-1/CD95). Nature 373:438.
3. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
4. Van Parijs, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
5. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609.
6. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614.
7. Antonsson, B., F. Conti, A. Ciavatta, S. Montessuit, S. Lewis, I. Martinou, L. Bernasconi, A. Bernard, J. J. Mermod, G. Mazzei, et al. 1997. Inhibition of Bax channel-forming activity by Bcl-2. Science 277:370.
8. Reed, J. C. 1997. Double identity for proteins of the Bcl-2 family. Nature 387: 773.
9. Schlesinger, P. H., A. Gross, X. M. Yin, K. Yamamoto, M. Saito, G. Waksman, and S. J. Korsmeyer. 1997. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl Acad. Sci. USA 94: 11357.
10. Strasser, A., A. W. Harris, and S. Cory. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889.
11. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
12. Singer, G. G., and A. K. Abbas. 1994. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
13. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
14. Van Parijs, L., D. A. Peterson, and A. K. Abbas. 1998. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8:265.
15. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190.
16. Boldin, M. P., T. M. Goncharov, Y. V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803.
17. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-likc protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell 85:817.
18. Di Somma, M. M., F. Somma, M. S. Gilardini Montani, R. Mangiacasale, E. Cundari, and E. Piccolella. 1999. TCR engagement regulates differential responsiveness of human T cells to Fas (CD95)-mediated apoptosis. J. Immunol. 162:3851.
19. Peter, M. E., F. C. Kischkel, C. G. Scheuerpflug, J. P. Medema, K. M. Debatin, and P. H. Krammer. 1997. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/ caspase 8) to the CD95 death-inducing signaling complex. Eur. J. Immunol. 27:1207.
20. Choy, E. H., J. Adjaye, L. Forrest, G. H. Kingsley, and G. S. Panayi. 1993. Chimaeric anti-CD4 monoclonal antibody cross-linked by monocyte Fcγ receptor mediates apoptosis of human CD4 lymphocytes. Eur. J. Immunol. 23:2676.
21. Oyaizu, N., T. W. McCloskey, S. Than, R. Hu, V. S. Kalyanaraman, and S. Pahwa. 1994. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 84:2622.
22. Oberg, H. H., R. Sanzenbacher, B. Lengl-Janssen, T. Dobmeyer, S. Flindt, O. Janssen, and D. Kabelitz. 1997. Ligation of cell surface CD4 inhibits activation-induced death of human T lymphocytes at the level of Fas ligand expression. J. Immunol. 159:5742.
23. Algeciras, A., D. H. Dockrell, D. H. Lynch, and C. V. Paya. 1998. CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J. Exp. Med. 187:711.
24. O'Neill, J. K., D. Baker, A. N. Davison, S. J. Allen, C. Butter, H. Waldmann, and J. L. Turk. 1993. Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies. J. Neuroimmunol. 45:1.
25. Moreland, L. W., P. W. Pratt, M. D. Mayes, A. Postlethwaite, M. H. Weisman, T. Schnitzer, R. Lightfoot, L. Calabrese, D. J. Zelinger, and J. N. Woody, et al. 1995. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. Arthritis Rheum. 38:1581.
26. Mauri, C., C. Q. Chu, D. Woodrow, L. Mori, and M. Londei. 1997. Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody. J. Immunol. 159:5032.
27. + T cell regulation during the induction phase of the response. Eur. J. Immunol. 25:2643.
28. Waldmann, H., and S. Cobbold. 1998. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Anna. Rev. Immunol. 619.
29. Kaplan, D., and S. Sieg. 1998. Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease. J. Virol. 72:6279.
30. Badley, A. D., K. Parato, D. W. Cameron, S. Kravcik, B. N. Phenix, D. Ashby, A. Kumar, D. H. Lynch, J. Tschopp, and J. B. Angel. 1999. Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ. 6:420.
31. + T cells in vivo by the induction of apoptosis? Immunol. Cell Biol. 77:90.
32. Wang, Z. Q., A. Dudhane, T. Orlikowsky, K. Clarke, X. Li, Z. Darzynkiewicz, and M. K. Hoffmann. 1994. CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur. J. Immunol. 24:1549.
33. + T cell depletion in mice doubly transgenic for HIV gp120 and human CD4. Eur. J. Immunol. 27:1319.
34. Kang, Y., E. F. Melo, and D. W. Scott. 1998. An ongoing immune response to HIV envelope gp120 in human CD4-transgenic mice contributes to T cell decline upon intravenous administration of gp120. Eur. J. Immunol. 28:2253.
35. + T cell populations. Eur. J. Immunol. 25:2907.
36. Dodi, A. I., S. Brett, T. Nordeng, S. Sidhu, R. J. Batchelor, G. Lombardi, O. Bakke, and R. I. Lechler. 1994. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line. Eur. J. Immunol. 24:1632.
37. + T cells from HIV-gp120-induced apoptosis. Eur. J. Immunol. 25:2917.
38. Tuosto, L., E. Cundari, M. S. Montani, and E. Piccolella. 1994. Analysis of susceptibility of mature human T lymphocytes to dexamethasone-induced apoptosis. Eur. J. Immunol. 24:1061.
39. Butch, A. W., G. H. Chung, J. W. Hoffmann, and M. H. Nahm. 1993. Cytokine expression by germinal center cells. J. Immunol. 150:39.
40. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J. 14:1129.
41. Cossarizza, A., M. Baccarani-Contri, G. Kalashnikova, and C. Franceschi. 1993. A new method for the cytofluorometric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro1,1′,3,3′- tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 197:40.
42. + T cells via Fas/Fas ligand-mediated apoptosis. J. Immunol. 158:1503.
43. Scaffidi, C., S. Kirchhoff, P. H. Krammer, and M. E. Peter. 1999. Apoptosis signaling in lymphocytes. Curr. Opin. Immunol. 11:277.
44. Xiang, J., D. T. Chao, and S. J. Korsmeyer. 1996. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93:14559.
45. Katsikis, P. D., E. S. Wunderlich, C. A. Smith, L. A. Herzenberg, and L. A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:2029.
46. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185:55.
47. Algeciras-Schimnich, A., T. S. Griffith, D. H. Lynch, and C. V. Paya. 1999. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J. Immunol. 162:5205.
48. Hashimoto, F., N. Oyaizu, V. S. Kalyanaraman, and S. Pahwa. 1997. Modulation of Bcl-2 protein by CD4 cross-linking: a possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2. Blood 90:745.
49. Adachi, Y., N. Oyaizu, S. Than, T. W. McCloskey, and S. Pahwa. 1996. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2. J. Immunol. 157:4184.
50. Vella, A. T., S. Dow, T. A. Potter, J. Kappler, and P. Marrack. 1998. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95:3810.
51. Deng, G., and E. R. Podack. 1993. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene Bcl-2. Proc. Natl. Acad. Sci. USA 90:2189.
52. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8:89.
53. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwill, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
54. + T cells. Nat. Med. 4:1377.
55. Refaeli, Y., L. Van Parijs, C. A. London, J. Tschopp, and A. K. Abbas. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615.
56. Yang, Y., Z. H. Liu, C. F. Ware, and J. D. Ashwell. 1997. A cysteine protease inhibitor prevents activation-induced T-cell apoptosis and death of peripheral blood cells from human immunodeficiency virus-infected individuals by inhibiting upregulation of Fas ligand. Blood 89:550.
57. + T lymphocytes is not mediated by Fas-Fas ligand. AIDS 11:1671.
58. lck in T-cell receptor/CD3-mediated apoptosis and Fas-ligand induction in Jurkat cells. Biochem. Biophys. Res. Commun. 213:994.
59. Gonzalez-Garcia, A., L. R-Borlado, E. Leonardo, I. Merida, C. Martinez-A. and A.C. Carrera. 1997. Lck is necessary and sufficient for Fas-ligand expression and apoptotic cell death in mature cycling T cells. J. Immunol. 158:4104.
60. Latinis, K. M., L. L. Carr, E. J. Peterson, L. A. Norian, S. L. Eliason, and G. A. Koretzky. 1997. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158:4602.
61. Broome, H. E., C. M. Dargan, S. Krajewski, and J. C. Reed. 1995. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J. Immunol. 155:2311.
62. Knudson, C. M., and S. J. Korsmeyer. 1997. Bcl-2 and Bax function independently to regulate cell death. Nat. Genet. 16:358.
63. Gross, A., J. Jockel, M. C. Wei, and S. J. Korsmeyer. 1998. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17:3878.
64. Naka, T., T. Matsumoto, M. Narazaki, M. Fujimoto, Y. Morita, Y. Ohsawa, H. Saito, T. Nagasawa, Y. Uchiyama, and T. Kishimoto. 1998. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SS1-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA 95:15577.
65. Cossarizza, A., C. Mussini, N. Mongiardo, V. Borghi, A. Sabbatini, B. De Rienzo, and C. Franceschi. 1997. Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome. AIDS 11:19.
66. Debatin, K.-M., A. Fahrig-Faissner, S. Eneekel-Stoodt, W. Kreuz, A. Benner, and P. H. Krammer. 1994. High expression of APO-1 (CD95) on T-lymphocytes from HIV infected children. Blood 83:3101.
67. Gougeon, M. L., H. Lecoeur, A. Dulioust, M. G. Enouf, M. Crouvoisier, C. Goujard, T. Debord, and L. Montagnier. 1996. Programmed cell death in peripheral lymphocytes from HIV-infected persons. J. Immunol. 156:3509.
68. Bäumler, C. B., T. Böhler, I. Herr, A. Benner, P. H. Krammer, and K.-M. Debatin. 1996. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 88:1741.
69. + T cells by a Fas-independent mechanism. J. Exp. Med. 187:1113.
70. Ledru, E., H. Lecoeur, S. Garcia, T. Debord, and M. L. Gougeon. 1998. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J. Immunol. 160:3194.